World’s largest recording label teams with Portland startup MedRhythms on ‘prescription music’

Portland-based digital therapeutics startup MedRhythms Inc. is joining forces with Universal Music Group NV, the world’s largest music label, to bring “prescription music” to patients for the first time.

The partnership, announced Wednesday, will give MedRhythms access to nearly all of Universal’s catalog of millions of songs for the MedRhythms platform, which uses clinical sensors, software and music to help restore function lost to neurologic disease or injury.

“Since our product is based upon the neuroscience of music, and will be approved by the FDA as a prescription-only product, this means that the only way the product will be available to patients is through a prescription from a doctor,” Brian Harris, the company’s CEO and co-founder, told Mainebiz. “Once we receive FDA approval, we will be the world’s first prescription music platform.” Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025